Elon Musk’s Ozempic Revelation Sparks Outrage and Hypocrisy Accusations
Elon Musk’s Christmas “Ozempic Santa” post revealed his use of the weight-loss drug Mounjaro, sparking further debate on GLP-1 inhibitors. This follows a recent disagreement with Robert F. Kennedy Jr., Trump’s HHS appointee, over the cost-effectiveness of widespread GLP-1 inhibitor use versus promoting healthier lifestyles to combat obesity. Musk advocates for making these drugs affordable, contrasting Kennedy’s initial focus on dietary changes. Musk’s public endorsement, however, adds another layer to the ongoing discussion surrounding obesity treatment in America.
John Q. Hosedrinker